Navigation Links
Amgen's First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
Date:4/23/2009

structuring related costs. (f) To exclude the ongoing, non-cash amortization of the R&D technology intangible assets acquired with the Abgenix and Avidia acquisitions. (g) To exclude the net tax benefit resulting from adjustments to previously established deferred taxes, primarily related to prior acquisitions and stock option expense, due to changes in California tax law effective for future periods.
    CONTACT: Amgen, Thousand Oaks
             David Polk, 805-447-4613 (media)
             Arvind Sood, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Northridge, CA (PRWEB) March 30, 2015 ... special promotion on Invisalign. Eligible patients will receive $200 ... but are not particularly interested in wearing a mouthful ... Arami’s team, “The use of traditional braces is effective ... people who are already concerned with their oral appearance. ...
(Date:3/30/2015)... March 30, 2015 On March 27th, ... for yellow to inspire courage in Seth Lane, a ... Combined Immunodeficiency (SCID). SCID causes affected individuals to be ... is needed to allow the development of functional immune ... Friday, created a video with his family requesting its ...
(Date:3/30/2015)... 30, 2015 V/NO (Virtually No Alcohol) Wines ... flute for opening/closing and for reuse. Consumers simply twist the ... Health-conscious New Yorkers, professionals, and basically anyone can now enjoy ... to kick back socially or pair with meals at work, ... is dealcoholized wine and that means Napa Wine grapes ...
(Date:3/30/2015)... 2015 Software applications from five ... the second AS4 test and certification event, announced ... in interoperability software testing. New software applications from ... participated in this vendor-neutral test event which began ... interoperability certifications for IBM, Oracle and Software AG, ...
(Date:3/30/2015)... Segundo, CA (PRWEB) March 30, 2015 Corra ... tests to accommodate the needs of every industry that requires ... employers face compliance mandates or seek new ways to increase ... adding new drug panels that will help detect substance abuse ... industries have mandated drug tests,” said Corra Group Co-Founder, Gordon ...
Breaking Medicine News(10 mins):Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 3Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3
... Stereotaxis, Inc.,(Nasdaq: STXS ) today announced ... institutional investors to raise gross proceeds of $20,million through ... separate,concurrent transactions. A portion of the warrants sold will ... warrants would provide an additional,approximately $10 million in gross ...
... about possible outcomes, study finds , , MONDAY, Dec. 29 ... ill patients want doctors to frankly discuss the patient,s prognosis ... , The University of San Francisco Medical Center study, ... Journal of Respiratory and Critical Care Medicine , points out ...
... Calif., Dec. 29 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its management is scheduled to ... in New York, on Wednesday, January 7, 2009 at ... the presentation will be available online from the investor ...
... LCAV ) Board of Directors strongly opposes the consent ... that the Company has undertaken a prudent and achievable strategic ... Joffe intervention is a poorly designed effort to take control ... Joffe effort is an undue distraction to the Company that ...
... Directory on Internet - , , ANTHEM, Ariz., ... announced launch of its new web site at http://www.mychoicedentist.com ... in the Phoenix , Arizona, area is proceeding successfully. ... Chris Theotocatos, CEO. "We anticipate expanding this service to almost ...
... Plans New Products and Expanded Services in 2009 , ... ... has reported its seventh consecutive year of revenue growth in 2008, ... demand for media relations and marketing services provided by its HRmarketer ...
Cached Medicine News:Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 3Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 4Health News:Family Needs to Know When Patient Survival Is Uncertain 2Health News:Accuray Incorporated to Present at 11th Annual Needham Growth Stock Conference 2Health News:LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group's Threatened Consent Solicitation 2Health News:Prime Companies Announces Launch of New Dental Web Site 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 2Health News:Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability 3
(Date:3/30/2015)... 30, 2015 DURECT Corporation (Nasdaq: ... a multi-dose Phase 1 clinical trial of an ... DURECT,s Epigenomic Regulator Program.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ...  It may also play an important role in ...
(Date:3/30/2015)... 2015  BioPharmX Corporation (OTCQB: BPMX), a specialty ... drug delivery products to address unmet needs in ... appointment of Stephen Morlock , a seasoned ... board of directors.  Mr. Morlock,s background will assist ... national roll-out of Violet iodine, the new, once-daily, ...
(Date:3/30/2015)... DUBLIN , Mar. 25, 2015 Research and ... addition of the "Global Healthcare Cloud Computing Market ... analysts forecast the Global Healthcare Cloud Computing market to ... period 2014-2019. Increased adoption of IT in ... of cloud computing by the Global Healthcare industry. Though ...
Breaking Medicine Technology:DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Global Healthcare Cloud Computing Market 2015-2019 with Agfa, CareCloud, Carestream Health, Cisco, ClearData Networks, Dell, GE & Merge Healthcare Dominating 2
... CAMBRIDGE, Mass., Sept. 21, 2011 IntelligentMDx (IMDx) announced today ... test for the Abbott FDA cleared m 2000 instrument. ... detects and distinguishes the vanA and vanB ... specimens from patients at risk for colonization or infection. Detection ...
... 21, 2011 Mylan Inc. (Nasdaq: MYL ... settlement and license agreement with Hoffman La Roche Inc. ... 500 mg, USP, known generically as Capecitabine Tablets. This ... the treatment of metastatic breast and colorectal cancers. ...
Cached Medicine Technology:IntelligentMDx (IMDx) Introduces a CE-Marked Automated Molecular Test for the Detection of Vancomycin Resistance Genes vanA and vanB Most Commonly Found in Vancomycin-Resistant Enterococci 2Mylan Announces XELODA® Settlement and License Agreement 2
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...
The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
Medicine Products: